DrugJul 8, 2026
Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle recall — FDA D-0676-2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Class IIFDA: OngoingCipla USA, Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 6
10,685 detailed records are currently available in this category.
DrugJul 8, 2026
Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle recall — FDA D-0675-2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Class IIFDA: OngoingCipla USA, Inc.
DrugJul 8, 2026
Blaine Labs vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle recall — FDA D-0696-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc.
DrugJul 8, 2026
Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule recall — FDA D-0659-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingAsclemed USA Inc.
DrugJul 8, 2026
IMULDOSA recall — FDA D-0653-2026
Lack of assurance of Sterility:
Class IIFDA: OngoingACCORD BIOPHARMA Inc.
DrugJul 8, 2026
TRIDERGEL TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall — FDA D-0693-2026
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Class IIFDA: OngoingBlaine Labs Inc.
DrugJul 8, 2026
TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles recall — FDA D-0695-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc.
DrugJul 8, 2026
CHLORAPREP ONE-STEP BD ChloraPrep Hi-Lite Orange recall — FDA D-0647-2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the…
Class IIFDA: OngoingCareFusion 213, LLC
DrugJul 8, 2026
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous recall — FDA D-0714-2026
Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Class IIFDA: OngoingMcKesson
DrugJul 8, 2026
CHLORAPREP ONE-STEP BD ChloraPrep Scrub Teal recall — FDA D-0649-2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the…
Class IIFDA: OngoingCareFusion 213, LLC
DrugJul 8, 2026
CHLORAPREP ONE-STEP BD ChloraPrep Hi-Lite Orange recall — FDA D-0648-2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the…
Class IIFDA: OngoingCareFusion 213, LLC
DrugJul 8, 2026
CHLORAPREP ONE-STEP BD ChloraPrep Clear recall — FDA D-0645-2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the…
Class IIFDA: OngoingCareFusion 213, LLC
DrugJul 8, 2026
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recall — FDA D-0660-2026
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Class IIFDA: OngoingLannett Company Inc.
DrugJul 8, 2026
Boehringer Ingelheim Pharmaceuticals Synjardy XR Tablets recall — FDA D-0657-2026
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Class IIFDA: OngoingBoehringer Ingelheim Pharmaceuticals, Inc.
DrugJul 1, 2026
Lacosamide Tablets, USP, C V, 100mg recall — FDA D-0626-2026
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Class IIFDA: OngoingAnnora Pharma Private Limited
DrugJul 1, 2026
CHLORAPREP ONE-STEP BD ChloraPrep Clear recall — FDA D-0622-2026
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Class IIFDA: OngoingCareFusion 213, LLC
DrugJul 1, 2026
CHLORAPREP ONE-STEP BD ChloraPrep FREPP Clear recall — FDA D-0623-2026
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Class IIFDA: OngoingCareFusion 213, LLC
DrugJul 1, 2026
Central Admixture Pharmacy Services Total Parental Nutrition - Pediatric PN Patient-Specific recall — FDA D-0618-2026
Incorrect product formulation: bag did not contain copper and famotidine per label.
Class IIFDA: OngoingCentral Admixture Pharmacy Services, Inc.
DrugJul 1, 2026
METHYLERGONOVINE MALEATE Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg recall — FDA D-0609-2026
Subpotent Drug
Class IIFDA: OngoingThe Harvard Drug Group LLC
DrugJul 1, 2026
CHLORAPREP ONE-STEP BD ChloraPrep Clear recall — FDA D-0624-2026
Non-Sterility: Due to presence of Aspergillus penicillioides.
Class IFDA: OngoingCareFusion 213, LLC
DrugJul 1, 2026
Perampanel CIII Tablets, 6mg recall — FDA D-0628-2026
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES INC
DrugJul 1, 2026
CHLORAPREP ONE-STEP BD ChloraPrep FREPP Clear recall — FDA D-0625-2026
Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Class IFDA: OngoingCareFusion 213, LLC
DrugJun 24, 2026
HEALTH-TEC TOPICAL ANESTHETIC DHP Topical Anesthetic Gel, Benzocaine 20%, Strawberry Flavor recall — FDA D-0602-2026
Defective container:may contain bottles with incomplete seals
Class IIFDA: OngoingKeystone Industries
DrugJun 24, 2026
Dabur India Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc 400 units recall — FDA D-0633-2026
CGMP Deviations; deficiencies observed during FDA inspection
Class IIFDA: OngoingDabur India Limited
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.